Literature DB >> 27357149

Resident T Cells Are Unable To Control Herpes Simplex Virus-1 Activity in the Brain Ependymal Region during Latency.

Chandra M Menendez1, Jeremy K Jinkins2, Daniel J J Carr3.   

Abstract

HSV type 1 (HSV-1) is one of the leading etiologies of sporadic viral encephalitis. Early antiviral intervention is crucial to the survival of herpes simplex encephalitis patients; however, many survivors suffer from long-term neurologic deficits. It is currently understood that HSV-1 establishes a latent infection within sensory peripheral neurons throughout the life of the host. However, the tissue residence of latent virus, other than in sensory neurons, and the potential pathogenic consequences of latency remain enigmatic. In the current study, we characterized the lytic and latent infection of HSV-1 in the CNS in comparison with the peripheral nervous system following ocular infection in mice. We used RT-PCR to detect latency-associated transcripts and HSV-1 lytic cycle genes within the brain stem, the ependyma (EP), containing the limbic and cortical areas, which also harbor neural progenitor cells, in comparison with the trigeminal ganglia. Unexpectedly, HSV-1 lytic genes, usually identified during acute infection, are uniquely expressed in the EP 60 d postinfection when animals are no longer suffering from encephalitis. An inflammatory response was also mounted in the EP by the maintenance of resident memory T cells. However, EP T cells were incapable of controlling HSV-1 infection ex vivo and secreted less IFN-γ, which correlated with expression of a variety of exhaustion-related inhibitory markers. Collectively, our data suggest that the persistent viral lytic gene expression during latency is the cause of the chronic inflammatory response leading to the exhaustion of the resident T cells in the EP.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27357149      PMCID: PMC4975964          DOI: 10.4049/jimmunol.1600207

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  90 in total

1.  The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.

Authors:  Peter Härle; Bruno Sainz; Daniel J J Carr; William P Halford
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

2.  Postinfectious encephalopathy after treatment of herpes simplex encephalitis with acyclovir.

Authors:  J S Abramson; E S Roach; H B Levy
Journal:  Pediatr Infect Dis       Date:  1984 Mar-Apr

3.  Mechanisms of herpes simplex virus type 1 reactivation.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.

Authors:  Jennifer P Wang; Glennice N Bowen; Shenghua Zhou; Anna Cerny; An Zacharia; David M Knipe; Robert W Finberg; Evelyn A Kurt-Jones
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

6.  The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin.

Authors:  Laura K Mackay; Azad Rahimpour; Joel Z Ma; Nicholas Collins; Angus T Stock; Ming-Li Hafon; Javier Vega-Ramos; Pilar Lauzurica; Scott N Mueller; Tijana Stefanovic; David C Tscharke; William R Heath; Michael Inouye; Francis R Carbone; Thomas Gebhardt
Journal:  Nat Immunol       Date:  2013-10-27       Impact factor: 25.606

7.  Detection of HSV-1 genome in central nervous system of latently infected mice.

Authors:  D L Rock; N W Fraser
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

Review 8.  Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment.

Authors:  David W Kimberlin
Journal:  Herpes       Date:  2007-06

9.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 10.  Mucosal resident memory CD4 T cells in protection and immunopathology.

Authors:  Damian Lanz Turner; Donna L Farber
Journal:  Front Immunol       Date:  2014-07-14       Impact factor: 7.561

View more
  27 in total

1.  Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.

Authors:  Derek J Royer; Meghan M Carr; Ana J Chucair-Elliott; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

2.  Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system.

Authors:  Ana J Chucair-Elliott; Meghan M Carr; Daniel J J Carr
Journal:  J Leukoc Biol       Date:  2017-01-23       Impact factor: 4.962

Review 3.  Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection.

Authors:  Chandra M Menendez; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2017-03-08       Impact factor: 3.478

4.  T cells establish and maintain CNS viral infection in HIV-infected humanized mice.

Authors:  Jenna B Honeycutt; Baolin Liao; Christopher C Nixon; Rachel A Cleary; William O Thayer; Shayla L Birath; Michael D Swanson; Patricia Sheridan; Oksana Zakharova; Francesca Prince; JoAnn Kuruc; Cynthia L Gay; Chris Evans; Joseph J Eron; Angela Wahl; J Victor Garcia
Journal:  J Clin Invest       Date:  2018-06-04       Impact factor: 14.808

5.  Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.

Authors:  Grzegorz B Gmyrek; Adrian Filiberti; Micaela Montgomery; Alisha Chitrakar; Derek J Royer; Daniel J J Carr
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

6.  Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge.

Authors:  Daniel J J Carr; Amanda N Berube; Adrian Filiberti; Grzegorz B Gmyrek
Journal:  Vaccine       Date:  2021-04-01       Impact factor: 3.641

7.  An intact complement system dampens cornea inflammation during acute primary HSV-1 infection.

Authors:  Adrian Filiberti; Grzegorz B Gmyrek; Amanda N Berube; Derek J Royer; Daniel J J Carr
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Differential Expression of Immune Checkpoint Molecules on CD8+ T Cells Specific for Immunodominant and Subdominant Herpes Simplex Virus 1 Epitopes.

Authors:  Kate L Carroll; Lyndsay Avery; Benjamin R Treat; Lawrence P Kane; Paul R Kinchington; Robert L Hendricks; Anthony J St Leger
Journal:  J Virol       Date:  2020-01-06       Impact factor: 6.549

Review 9.  Protective and Pathological Immunity during Central Nervous System Infections.

Authors:  Robyn S Klein; Christopher A Hunter
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 10.  Understanding polyomavirus CNS disease - a perspective from mouse models.

Authors:  Katelyn N Ayers; Sarah N Carey; Aron E Lukacher
Journal:  FEBS J       Date:  2021-07-02       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.